VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Telehealth Mindfulness-Based Music and Songwriting for Parents of Children With Intellectual/Developmental Disabilities

Not Applicable

Completed

Conditions: Stress
Autism Spectrum Disorder
Parents
Developmental Disability
Intellectual Disability

Interventions: Behavioral: Mindfulness-Based Music and Songwriting

First Posted Date: 2021-07-15

Last Posted Date: 2022-11-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 33

Registration Number: NCT04962659

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Cognitive Training in Survivors of Covid-19: A Randomized Trial

Not Applicable

Active, not recruiting

Conditions: Covid19
Cognitive Impairment

Interventions: Other: Control Group
Behavioral: AKL-T01

First Posted Date: 2021-07-09

Last Posted Date: 2024-04-22

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 100

Registration Number: NCT04956887

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Can COVID-19 Persist in Intraocular Fluid?

Completed

Conditions: Ocular Infection, Viral

Interventions: Procedure: routine care intraocular sx

First Posted Date: 2021-06-30

Last Posted Date: 2022-03-23

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 25

Registration Number: NCT04945850

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

Phase 2

Recruiting

Conditions: Familial Hypercholesterolemia

Interventions: Drug: 2-Hydroxybenzylamine
Other: Placebo

First Posted Date: 2021-06-28

Last Posted Date: 2024-12-13

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 72

Registration Number: NCT04941599

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

"CHANGE COVID-19 Severity"

Phase 1

Terminated

Conditions: COVID-19 Infection

Interventions: Drug: Magnesium Citrate plus probiotic

First Posted Date: 2021-06-28

Last Posted Date: 2023-11-13

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 23

Registration Number: NCT04941703

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

PeerNaija: A Mobile Health Platform Incentivizing Medication Adherence Among Youth Living With HIV in Nigeria

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: PeerNaija

First Posted Date: 2021-06-18

Last Posted Date: 2024-05-10

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 57

Registration Number: NCT04930198

Locations: 🇳🇬
Nigerian Institute of Medical Researd, Lagos, Nigeria
🇳🇬
APIN Public Health Initiatives, Abuja, Nigeria

Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer

Not Applicable

Active, not recruiting

Conditions: Kidney Cancer

Interventions: Procedure: Standard Blood Replacement
Procedure: Blood Sparing Protocol

First Posted Date: 2021-06-10

Last Posted Date: 2023-10-03

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 240

Registration Number: NCT04922307

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
Winship Cancer Institute at Emory University, Atlanta, Georgia, United States

Here's the Buzz: Evaluating Pediatric Post Op Pain and Nausea Following Tonsillectomy Surgery

Not Applicable

Withdrawn

Conditions: Tonsillectomy

Interventions: Other: Standard of Care
Dietary Supplement: Honey

First Posted Date: 2021-06-02

Last Posted Date: 2022-07-07

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT04910919

Locations: 🇺🇸
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States

Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

Phase 1

Completed

Conditions: Pulmonary Arterial Hypertension
Familial Primary Pulmonary Hypertension
Primary Pulmonary Hypertension
Lung Diseases
Carnitine Nutritional Deficiency

Interventions: Dietary Supplement: L-carnitine

First Posted Date: 2021-06-01

Last Posted Date: 2024-02-14

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 10

Registration Number: NCT04908397

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot

Phase 1

Completed

Conditions: Obesity
Pre-diabetes

Interventions: Drug: Empagliflozin 25 MG

First Posted Date: 2021-05-28

Last Posted Date: 2023-12-29

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 29

Registration Number: NCT04907214

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy